🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kaustav Khatua

Mitchell Institute

ORCID: 0000-0002-2497-3187

Also affiliated with Drug Discovery Laboratory (Norway), Texas A&M University

Computer ScienceMedicineNursingChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors”.

The P3 O - Tert -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.18.473326

N/A

0DataRank · unranked

3 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +12 more

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114596

N/A

0DataRank · unranked

55 citations

Zhi Geng, Kai S. Yang, Namir Shaabani, Kaustav Khatua, R. Xinyu +13 more

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114570

N/A

0DataRank · unranked

43 citations

Kai S. Yang, Zhi Geng, Yugendar R. Alugubelli, Namir Shaabani, Erol C. Vatansever +13 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00221

N/A

0DataRank · unranked

25 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.29.560163

N/A

0DataRank · unranked

9 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Yuying Ma, R. Xinyu +8 more

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.17.524469

N/A

0DataRank · unranked

4 citations

Sandeep Atla, Namir Shaabani, Veerabhadra R. Vulupala, Kai S. Yang, Yugendar R. Alugubelli +13 more

An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.11.536467

N/A

0DataRank · unranked

3 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +14 more

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.3c02416

N/A

0DataRank · unranked

75 citations

Jing Xiao, Kaustav Khatua, Sathish Kumar, Long Sun, Yuying Ma +10 more

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.4c00146

N/A

0DataRank · unranked

12 citations

Kai S. Yang, Veerabhadra R. Vulupala, Yugendar R. Alugubelli, Kaustav Khatua, Demonta Coleman +8 more

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Antiviral Research(2024)10.1016/j.antiviral.2024.105874

N/A

0DataRank · unranked

11 citations

Yugendar R. Alugubelli, Kai S. Yang, Veerabhadra R. Vulupala, Lauren R. Blankenship, Demonta Coleman +15 more